Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1987-03-09
1990-07-24
Weimar, Elizabeth C.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
435948, 530387, 424 858, C12N 500, C12R 191, C07K 1512, A61K 39395
Patent
active
049435337
ABSTRACT:
Hybrid cell lines that synthesize and secrete monoclonal antibodies against epidermal growth factor receptor generated by the fusion of myeloma cells to lymphocytes immunized with epidermal growth factor receptor are disclosed. The method of generating the hybridomas, as well as therapeutic and diagnostic uses of the monoclonal antibodies in both cancer treatment and research are also disclosed.
REFERENCES:
Cohen et al., "Epidermal Growth Factor-Receptor-Protein Kinase Interactions", J. Biol. Chem., vol. 255, no. 10; 1980; pp. 4834-4842.
Grimm et al., "Immunoprecipitation of the EGF Receptor Using Hybridoma Antibodies"; J. Supramol. Structure; vol. 9 (Suppl. 4), Abstract 437; 1980; p. 167.
Schreiber et al.; "Monoclonal Antibodies Against Receptor for Epidermal Growth Factor Induce Early and Delayed Effects of Epidermal"Growth Factor; PNAS, vol. 78, no. 12, Dec. 1981, pp. 7535-7539.
Sato et al., "Biological Effects in Vitro of Monoclonal Antibodies to Human Epidermal Growth Factor Receptors"; Mol. Biol. Med., vol. 1, no. 15; Aug. 1983; pp. 511-529.
Beheadian et al.; "Isolation of a Variant of A431 Cells Using a Ricin A-Conjugated Monoclonal Antibody Directed to EGF Receptors", J. Cell Biology, vol. 97 (5 Part 2), Abstract #1540, Aug., 1983; p. 408a.
Waterfield et al., "A Monoclonal Antibody to the Human Epidermal Growth Factor Receptor"; J. Cellular Biochem., vol. 20; 1982; pp. 149-161.
Schreiber et al., "Biological Role of Epidermal Growth Factor-Receptor Clustering"; J. Biol. Chem., vol. 258, no. 2, Jan. 25, 1983; pp. 846-853.
Grimm et al., "Hybridoma Antibodies to A431 Cell Plasma Membranes: Tests for Specific Immunoprecipitation of EGF Receptors", in Monoclonal Antibodies in Endocrine Research Raven Press, New York Eisenbarth (Ed.), 1981 pp. 99-110.
Gooi et al., "The Carbohydrate Specificities of the Monoclonal Antibodies 29.1, 455 and 3C1B12 to the Epidermal Growth Factor Receptor of A431 Cells." Bioscience Reports. 1985. vol. 5, pp. 83-94.
Masui et al. "Growth Inhibition of Human Tumor Cells in Athymic Mice by Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies." Cancer Research. Mar. 1984. vol. 44, pp. 1002-1007.
Kawamoto, Tomoyuki, et al., "Growth Stimulation of A431 Cells by Epidermal Growth Factor: Identification of High-Affinity Receptors for Epidermal Growth Factor By an Anti-Receptor Monoclonal Antibody." Proceedings of the National Academy of Sciences, U.S.A., Mar. 1983, 80:1337-1341.
Cohen, Stanley, et al., "Epidermal Growth Factor-Receptor-Protein Kinase Interactions." The Journal of Biological Chemistry. May 25, 1980; vol. 255, no. 10: 4834-4842.
Linsley, Peter S., and C. Fred Fox. "Direct Linkage of EGF to Its Receptor: Characterization and Biological Relevance." Journal of Supramolecular Structure. 1980, 14:441-459.
Kawamoto Tomoyuki
Mendelsohn John
Sato Gordon
Sato J. Denry
The Regents of the University of California
Weimar Elizabeth C.
LandOfFree
Hybrid cell lines that produce monoclonal antibodies to epiderma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid cell lines that produce monoclonal antibodies to epiderma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid cell lines that produce monoclonal antibodies to epiderma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1267609